Connect with us

Technology

New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions

Published

on

NEWARK, N.J., March 26, 2025 /PRNewswire/ — The New Jersey Innovation Institute (NJII), and Cognome are pleased to announce a strategic partnership to transform patient care with AI and ML solutions. This partnership leverages Cognome’s ethical AI tools, developed at two leading academic healthcare systems, with NJII’s professional services to deliver next-generation clinical intelligence, operational efficiencies and outcomes improvement. Healthcare Innovation Solutions (HCIS), the Quality and Performance Improvement subsidiary of NJII, will play a key role in bringing these innovative and cutting-edge AI solutions to the marketplace.

“We are thrilled to partner with Cognome to advance AI and Machine Learning in healthcare,” says Jennifer D’Angelo, NJII’s COO and CEO of HCIS. “By aligning stakeholder initiatives, we can ensure all hospitals and providers benefit from AI-driven innovation, enhancing research, patient care, safety and operations.”

NJII, an NJIT corporation, is dedicated to accelerating healthcare technology and fostering innovation throughout New Jersey and beyond. Cognome, formed through a joint venture between Montefiore Health System and the University of Texas at Houston, offers advanced AI and Machine Learning models, as well as the first-of-its-kind AI Governance platform, ExplainerAITM, purpose-built for healthcare. For over a decade, NJII has been a trusted leader in healthcare technology, data interoperability, and care transformation. NJII aims to drive AI adoption starting with proper governance, model implementation and co-development with our healthcare partners.

“This partnership aligns with our commitment to accelerate innovation in key sectors such as healthcare,” says Tom Villani, PhD, NJII’s VP of AI and Machine Learning. “All of our AI models integrate seamlessly with EHRs, delivering real-time insights to physicians. The Sepsis reduction model has demonstrated the lowest flag rate in the industry. AutoChart AI reduces manual chart abstraction by over 90%, providing significant ROI through operational efficiencies and prospective attribution.”

The ExplainerAI™ platform, built on the NIH AI Governance framework, enhances trustworthiness and transparency while reducing bias through responsible AI models—crucial for clinician adoption. It also aligns with NIST’s AI Risk Management Framework addressing the need for proper privacy, auditability, cybersecurity and compliance for AI models including those from third parties.”

“Partnering with NJII combines our 15 years of building proven AI and ML capabilities with their deep knowledge and collaboration throughout NJ’s healthcare ecosystem,” says James Green, Cognome’s CEO. “Size and diversity in patient data are the ‘fuel’ for intelligent, accurate, and responsible AI models.”

The partnership will bring together healthcare delivery stakeholders including researchers, technology leaders, AI/ML practitioners as well as operational and quality teams to collaborate on high-value use cases. NJII will also provide data science expertise and custom model development services to meet the growing demand for advanced analytics and purpose-built AI solutions.

To learn more about this partnership, focused on delivering high-value operational and clinical use cases, join our upcoming Webinar: Accelerating AI Adoption in NJ Healthcare: Collaboration & Real-World Impact – on April 29th at 12pm EDT. Register now.

For more information, visit 

NJII – New Jersey Innovation Institute (NJII) | An NJIT Corporation 

HCIS – Healthcare Innovation Solutions, Inc. (HCIS)

Cognome – AI-Powered Healthcare and Clinical Decision-Making | Cognome 

About NJII and Healthcare Innovation Solutions (HCIS): 
 NJII, a 501c3 non-profit subsidiary of NJIT, turns ideas into workable solutions in healthcare, strategic partnerships, defense, and education. NJII combines NJIT’s resources and strong industry ties to drive innovation that impacts the economy and public welfare. HCIS, a wholly owned subsidiary of NJII, provides quality and performance improvement solutions that help providers succeed with population health and value-based care programs such as MIPS/MVPs, QIP-NJ, TEAM and others.

About Cognome: With 15+ years of R&D, seven patents, and real-time AI and ML models deployed across 20+ hospitals, Cognome is revolutionizing how healthcare data transforms care delivery, clinical operations, and medical research.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-jersey-innovation-institute-and-cognome-announce-strategic-partnership-to-advance-ai-powered-healthcare-solutions-302412169.html

SOURCE New Jersey Innovation Institute

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Yon Raz-Fridman Joins Intrinsic Labs as Co-Founder and Partner

Published

on

By

Most AI companies are selling software. Intrinsic is deploying AI workers into the core operations of mid-market companies – and just brought in a serial tech entrepreneur to help the firm scale across the Heartland.

COLUMBUS, Ohio, April 30, 2026 /PRNewswire/ — Intrinsic Labs today announced that Yon Raz-Fridman has joined the firm as a Co-Founder and Partner.

Raz-Fridman has spent nearly two decades building across software, hardware, and platform businesses. Early in his career, he served as Chief of Staff to the President of Keter Group, a $1 billion-plus global consumer products manufacturer. He went on to co-found Kano, the award-winning educational computing company, and later founded Supersocial, the immersive gaming studio acquired by Super League Enterprises in 2025. He is a member of the World Economic Forum’s Technology Convergence Council.

He joins Intrinsic at a moment when mid-market companies are moving from AI experimentation to deployment. Intrinsic works with operators in logistics, construction, insurance, manufacturing, and industrial markets to deploy AI workers into the workflows that run the business – increasing throughput, reducing manual work, and expanding capacity without adding headcount.

The firm has built its reputation on practical deployments tied to real operating metrics. In one engagement with a national real estate brokerage, Intrinsic’s AI Accounting Agents reached 97% invoice coding accuracy, automated 90% of the AP workflow, and fully removed FTEs from the review flow.

“Yon understands what it takes to build and scale in the real world,” said Jon Slemp, Managing Partner at Intrinsic Labs. “Our clients aren’t buying flashy agents, they’re buying outcomes and reliable labor. They need agentic systems that take work off their teams, perform reliably, and produce measurable gains in throughput and capacity. That’s what we build.”

As Co-Founder, Raz-Fridman will oversee Intrinsic’s expansion – designing the channel relationships, institutional partnerships, and market positioning that take the firm from a proven Ohio model to the defining AI workforce platform for America’s industrial middle market.

“The companies that win over the next decade will be the ones that figure out how to staff AI into their operations and manage it like a workforce. Intrinsic is doing that work now, inside real businesses, tied to real outputs. The Heartland is exactly the right place to prove this model, and Intrinsic is exactly the right team to do it.” — Yon Raz-Fridman

About Intrinsic Labs LLC
Intrinsic Labs helps mid-market companies deploy AI workers into the workflows that run their business. The firm focuses on logistics, construction, insurance, manufacturing, and industrial markets, where manual work, fragmented systems, and labor constraints create clear opportunities for leverage. Intrinsic works with clients to put AI workers into production, tie them to operating KPIs, and help teams scale output without scaling headcount. https://www.intrinsic-labs.ai/  

About Team Yon LLC
Team Yon LLC is a management company founded by Yon Raz-Fridman that incubates new ventures, provides executive leadership, and makes strategic investments at the intersection of emerging technology and human advancement. Through Team Yon LLC, Raz-Fridman partners with founders and operators across healthcare, AI, and frontier technology – including his role as co-founder and Partner at Intrinsic Labs. https://teamyon.org

Media Contact:hello@intrinsic-labs.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/yon-raz-fridman-joins-intrinsic-labs-as-co-founder-and-partner-302756994.html

SOURCE Team Yon LLC

Continue Reading

Technology

Wipfli to complete CompliancePoint transaction and add associates, expanding capabilities

Published

on

By

MILWAUKEE, April 30, 2026 /PRNewswire/ — Wipfli, a top 25 national advisory and accounting firm, announced today it has entered into an agreement with CompliancePoint Inc., a provider of risk management services focused on information security, data privacy and regulatory compliance. 2 partners and 52 associates will join the firm as a result of the transaction.

Based in Duluth, Georgia, CompliancePoint brings specialization across cybersecurity, privacy and compliance, serving clients across a wide variety of industries. The addition strengthens Wipfli’s risk management offerings and expands its ability to help organizations navigate regulatory scrutiny, evolving cybersecurity threats and complex data protection requirements.

“Organizations today are under more pressure than ever to protect sensitive information and operate responsibly in an evolving regulatory environment,” said Kurt Gresens, CEO at Wipfli Advisory, LLC. “The team at CompliancePoint brings specialized experience and a strong, people-first approach that enhances how we support clients navigating today’s risk landscape.”

CompliancePoint has built its reputation on helping organizations manage risk across the full data lifecycle, with a holistic approach that recognizes how privacy, security and compliance intersect. The combined professional teams from CompliancePoint and Wipfli will deliver expanded, integrated advisory solutions designed to help clients proactively manage risk while supporting long-term growth and operational resilience.

“Wipfli shares our commitment to practical, client-focused solutions and long-term relationships,” said Greg Sparrow, CompliancePoint president. “Together, we’re expanding the resources available to our clients while continuing to deliver the specialized experience and trusted relationships they rely on.”

The addition of the CompliancePoint team also supports Wipfli’s continued investment in talent and innovation. CompliancePoint associates will join a national firm that emphasizes collaboration, professional development and meaningful client impact, while maintaining the specialized focus that has defined their work.

The transaction is expected to become effective on May 1st, 2026

About Wipfli

Wipfli is a leading national advisory and accounting firm with nearly 100 years of experience serving ambitious middle-market organizations. We understand our clients’ unique challenges and help them succeed on their terms through assurance, tax, advisory, outsourcing and technology services. With 3,000+ associates and global alliances, we combine national capabilities with local relationships. Wipfli operates under an alternative practice structure: Wipfli LLP, a licensed CPA firm, provides attest services, while Wipfli Advisory LLC, a non-CPA firm, delivers business advisory and non-attest services. Learn more at wipfli.com or contact Alicia O’Connell at alicia.oconnell@wipfli.com.

Media Contact

Alicia O’Connell
Wipfli
alicia.oconnell@wipfli.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wipfli-to-complete-compliancepoint-transaction-and-add-associates-expanding-capabilities-302756208.html

SOURCE Wipfli

Continue Reading

Technology

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Published

on

By

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026

BOSTON, April 30, 2026 /PRNewswire/ — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, beginning at 4:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo’s investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. The company offers autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo’s in-house autonomous lab is also available as a “cloud lab” through our Datapoints and Solutions contract research services. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com 

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2026-results-presentation-302757632.html

SOURCE Ginkgo Bioworks

Continue Reading

Trending